Progress in the treatment of postoperative delirium with chemical medications

doi:10.3868/j.issn.2096-0689.2024.04.003

Journal of Translational Neuroscience

2024, Vol. 9

Issue (4) : 23-31 https://doi.org/10.3868/j.issn.2096-0689.2024.04.003

Review

Progress in the treatment of postoperative delirium with chemical medications

Zihan Chu^1#, Xi Wang^2#, Xueqi Fan³, Ning Wang^2*

1.College of Sciences, Northeastern University, Shenyang 110000, China
2.Center for Health Quality, National Research Institute for Family Planning, Beijing 100081, China
3.Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100005, China

Download: PDF(11247 KB)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract Postoperative delirium (POD) is a common postoperative complication that can lead to adverse consequences such as prolonged hospitalization, increased medical costs, and higher patient mortality. Chemical medications have demonstrated effectiveness as an intervention in the prevention and treatment of POD, and as a result, have garnered much research attention in recent years. The purpose of this paper is therefore to review and evaluate the research on chemical medications for the treatment of POD systematically, to summarize the current findings, and to discuss future directions.

Keywords postoperative delirium chemical medications treatment research progress

Issue Date: 25 December 2024

Cite this article:

Zihan Chu, Xi Wang, Xueqi Fan, Ning Wang. Progress in the treatment of postoperative delirium with chemical medications[J]. Journal of Translational Neuroscience,2024, 9(4): 23-31.

URL:

https://academic.hep.com.cn/jtn/EN/10.3868/j.issn.2096-0689.2024.04.003
https://academic.hep.com.cn/jtn/EN/Y2024/V9/I4/23

[1]	Hongrui Ma, Xunming Ji. Advances in the diagnosis and treatment of symptomatic intracranial atherosclerotic disease[J]. Journal of Translational Neuroscience, 2024, 9(4): 1-13.
[2]	Xueqi Fan, Xi Wang, Zihan Chu, Ning Wang. Research progress in prevention of postoperative delirium[J]. Journal of Translational Neuroscience, 2023, 8(4): 1-6.
[3]	Qiaoyan Liu, Yuming Wang, Aimin Zhang. Post-polio syndrome: a literature review[J]. Journal of Translational Neuroscience, 2020, 5(1): 1-7.
[4]	Wenlin Chen, Yang Ge, Yutian Wang. N-methyl-D-aspartate glutamate receptors (NMDARs) in stroke pathogenesis and treatments[J]. Journal of Translational Neuroscience, 2019, 4(4): 1-12.
[5]	Hua Gao, Jianhua Li, Yazhuo Zhang. The etiology, clinical features and medical treatment of somatotroph adenomas[J]. Journal of Translational Neuroscience, 2018, 3(1): 23-31.
[6]	Yue Fu, Jianping Jia. Hypertension and Alzheimer’s disease[J]. Journal of Translational Neuroscience, 2017, 2(3): 7-14.
[7]	Rena Li, Xin Ma, Gang Wang, Jian Yang, Chuanyue Wang. Why sex differences in schizophrenia?[J]. Journal of Translational Neuroscience, 2016, 1(1): 37-42.

Viewed

Full text

Abstract

Cited

Shared

Discussed